New drug could save eyes from cancer surgery
NCT ID NCT05907954
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 28 times
Summary
This study tests a drug called darovasertib in people with a rare eye cancer (uveal melanoma). The goal is to shrink tumors before standard treatment, possibly avoiding eye removal and reducing radiation damage. About 160 participants will take the drug by mouth to see if it controls the cancer and allows eye-saving treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UVEAL MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alfred Health
Melbourne, Victoria, 3004, Australia
-
Charité - Universitätsmedizin Berlin
Berlin, 12203, Germany
-
Fondazione IRCCS Istituto Nazionale Tumori
Milan, 20133, Italy
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Rome, 00168, Italy
-
HonorHealth Research Institute
Scottsdale, Arizona, 85258, United States
-
Institute Curie
Paris, 75005, France
-
Leiden University Medical Center
Leiden, 2333 ZA, Netherlands
-
Mayo Clinic Rochester
Rochester, Minnesota, 55905, United States
-
Moores Cancer Center
La Jolla, California, 92093, United States
-
Northwell
Manhasset, New York, 11030, United States
-
Princess Margaret Cancer Centre
Toronto, Ontario, M5G2M9, Canada
-
Sarah Cannon Research Institute
Nashville, Tennessee, 37203, United States
-
St. Vincent's Health Sydney
Sydney, New South Wales, 2010, Australia
-
Stanford Cancer Institute
Palo Alto, California, 94305, United States
-
The Cancer and Hematology Centers
Grand Rapids, Michigan, 49546, United States
-
Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
-
University of Miami
Miami, Florida, 33146, United States
-
University of Texas Southwestern Medical Center
Dallas, Texas, 75390, United States
Conditions
Explore the condition pages connected to this study.